(1) Background: The purpose of this study is to compare the performance of four breast cancer risk prediction models by race, molecular subtype, family history of breast cancer, age, and BMI. (2) Methods: Using a cohort of women aged 40–84 without prior history of breast cancer who underwent screening mammography from 2006 to 2015, we generated breast cancer risk estimates using the Breast Cancer Risk Assessment tool (BCRAT), BRCAPRO, Breast Cancer Surveillance Consortium (BCSC) and combined BRCAPRO+BCRAT models. Model calibration and discrimination were compared using observed-to-expected ratios (O/E) and the area under the receiver operator curve (AUC) among patients with at least five years of follow-up. (3) Results: We observed comparab...
The Gail model has been used to predict invasive breast cancer risk in women using risk factors of a...
Breast cancer (BC) risk assessment models base their estimations on different aspects of a woman’s p...
Background The Breast Cancer Risk Assessment Tool of the National Cancer Institute (NCI) is widely u...
ABSTRACT: INTRODUCTION: Clinicians use different breast cancer risk models for patients considered a...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Risk prediction models may be useful for precision breast cancer screening. We aimed to ...
Five-year absolute breast cancer risk prediction models are required to comply with national guideli...
Prospective validation of risk models is needed to assess their clinical utility, particularly over ...
Background: Several studies have proposed personalized strategies based on women's individual breast...
for estimating the risk of breast cancer in women participat-ing in a program of annual mammographic...
The integration of risk assessment into clinical breast screening holds promise in decreasing breast...
Abstract The USPSTF recommends that women who are at increased risk for breast cancer...
Abstract Background Breast cancer is a heterogeneous disease, divided into subtypes based on the exp...
BACKGROUND: Rigorous evaluation of the calibration and discrimination of breast-cancer risk-predicti...
Prospective validation of risk models is needed to assess their clinical utility, particularly over ...
The Gail model has been used to predict invasive breast cancer risk in women using risk factors of a...
Breast cancer (BC) risk assessment models base their estimations on different aspects of a woman’s p...
Background The Breast Cancer Risk Assessment Tool of the National Cancer Institute (NCI) is widely u...
ABSTRACT: INTRODUCTION: Clinicians use different breast cancer risk models for patients considered a...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Risk prediction models may be useful for precision breast cancer screening. We aimed to ...
Five-year absolute breast cancer risk prediction models are required to comply with national guideli...
Prospective validation of risk models is needed to assess their clinical utility, particularly over ...
Background: Several studies have proposed personalized strategies based on women's individual breast...
for estimating the risk of breast cancer in women participat-ing in a program of annual mammographic...
The integration of risk assessment into clinical breast screening holds promise in decreasing breast...
Abstract The USPSTF recommends that women who are at increased risk for breast cancer...
Abstract Background Breast cancer is a heterogeneous disease, divided into subtypes based on the exp...
BACKGROUND: Rigorous evaluation of the calibration and discrimination of breast-cancer risk-predicti...
Prospective validation of risk models is needed to assess their clinical utility, particularly over ...
The Gail model has been used to predict invasive breast cancer risk in women using risk factors of a...
Breast cancer (BC) risk assessment models base their estimations on different aspects of a woman’s p...
Background The Breast Cancer Risk Assessment Tool of the National Cancer Institute (NCI) is widely u...